Cargando…

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II

Detalles Bibliográficos
Autores principales:	Otero-Losada, Matilde, Gubellini, Paolo, Capani, Francisco, Perez-Lloret, Santiago
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868301/ https://www.ncbi.nlm.nih.gov/pubmed/36699074 http://dx.doi.org/10.3389/fphar.2022.1121513

Ejemplares similares

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Editorial: Neuroprotection in Synaptic Signalling During Neurological Disorders
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Editorial: Neuroprotection in Brain Hypoxia
por: Otero-Losada, Matilde, et al.
Publicado: (2019)

The Genetic Basis of Probable REM Sleep Behavior Disorder in Parkinson’s Disease
por: Perez-Lloret, Santiago, et al.
Publicado: (2023)

Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson's Disease Animal Models from a Molecular Signaling Perspective
por: Udovin, Lucas, et al.
Publicado: (2020)

Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic
por: Otero-Losada, Matilde, et al.
Publicado: (2020)

Genetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease, Results from a Cross-Sectional In Silico Study
por: Chevalier, Guenson, et al.
Publicado: (2023)

Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective
por: Bordet, Sofía, et al.
Publicado: (2023)

Editorial: Neurological comorbidity in metabolic syndrome
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Editorial: Neurobehavioral toxicity induced by environmental contaminants: mechanisms of neurodegeneration and neuroprotection, Volume II
por: Dorta, Daniel J., et al.
Publicado: (2023)

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
por: Pérez-Lloret, Santiago, et al.
Publicado: (2021)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective
por: Kobiec, Tamara, et al.
Publicado: (2023)

Corrigendum: Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective
por: Kobiec, Tamara, et al.
Publicado: (2023)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Neurodegeneration and Neuroprotection in Retinal Disease, Volume II
por: Casini, Giovanni, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Editorial: Applications of herbal medicine to control chronic kidney disease: Volume II
por: Chen, Jianping, et al.
Publicado: (2022)

Editorial: Bone and Cartilage Diseases – The Role and Potential of Natural Products, Volume II
por: Pei, Ming, et al.
Publicado: (2023)

Editorial: Eicosanoids in cancer, Volume II
por: Patrignani, Paola, et al.
Publicado: (2023)

The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene
por: Kobiec, Tamara, et al.
Publicado: (2021)

Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
por: Poirier, Andrée-Anne, et al.
Publicado: (2022)

Editorial: Natural products and brain energy metabolism: Astrocytes in neurodegenerative diseases Volume II
por: Wang, Fushun, et al.
Publicado: (2023)

Editorial: New trends in natural product research for inflammatory and infectious diseases: Volume II
por: Ribeiro-Filho, Jaime, et al.
Publicado: (2023)

Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome
por: Herrera, María I., et al.
Publicado: (2018)

Editorial: Reducing the harm of medication–recent trends in pharmacovigilance (volume II)
por: Ramírez, Elena, et al.
Publicado: (2023)

Editorial: Autoimmune and inflammatory rheumatic diseases: Identifying biomarkers of response to therapy with biologics: Volume II
por: Giuliani, Anna Lisa, et al.
Publicado: (2023)

Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
por: Miguelez, Cristina, et al.
Publicado: (2020)

Editorial: Venoms, animal and microbial toxins, volume II
por: Cao, Zhijian, et al.
Publicado: (2022)

Editorial: Current Aspects in Chemopreventive Strategies, Volume II
por: Tuli, Hardeep Singh, et al.
Publicado: (2022)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
por: Gomes, Paula, et al.
Publicado: (2023)

Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
por: Takahashi, Shinichi, et al.
Publicado: (2022)

Editorial: Apoptosis Induction/Suppression: A Feasible Approach for Natural Products to Treatment of Diseases, Volume II
por: Peng, Wei, et al.
Publicado: (2022)

Editorial: Neuroinflammatory and oxidative/nitrosative pathways in neuropsychiatric and neurological diseases and their possible neuropharmacological regulation, Volume II
por: Pereira, Marta P., et al.
Publicado: (2023)

A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis
por: Herrera, María Inés, et al.
Publicado: (2019)

Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
por: Patricio, Felipe, et al.
Publicado: (2020)

Neuroprotective Effects of Oligosaccharides From Periplaneta Americana on Parkinson’s Disease Models In Vitro and In Vivo
por: Liu, Miao-Miao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oip51u1s1ig9630ffu5e2jfhf4